Thompson Davis & Co’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
$3K Buy
+200
New +$3K 0.01% 646